"Designing Growth Strategies is in our DNA"
To get information on various segments, share your queries with us
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2021-2034 |
|
Base Year |
2025 |
|
Estimated Year |
2026 |
|
Forecast Period |
2026-2034 |
|
Historical Period |
2021-2024 |
|
Growth Rate |
CAGR of 6.5% from 2026-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
By Product Type, Guidance System, Application, End-User, and Region |
|
By Product Type |
· Core Needle Biopsy (CNB) Systems · Vacuum-Assisted Biopsy (VAB) Systems · Fine Needle Aspiration (FNA) Systems · Biopsy Needles · Specimen Handling Systems · Others |
|
By Guidance System |
· Ultrasound-guided Biopsy · MRI-guided Biopsy · Mammography-guided Biopsy · Others |
|
By Application |
· Screening · Diagnostics · Therapy Response Monitoring |
|
By End-User |
· Hospitals · Specialty Clinics · Diagnostic Centers · Others |
|
By Region |
· North America (By Product Type, Guidance System, Application, End-User, and Country) o U.S. § By Product Type o Canada § By Product Type · Europe (By Product Type, Guidance System, Application, End-User, and Country/Sub-region) o Germany § By Product Type o U.K. § By Product Type o France § By Product Type o Spain § By Product Type o Italy § By Product Type o Scandinavia § By Product Type o Rest of Europe § By Product Type · Asia Pacific (By Product Type, Guidance System, Application, End-User, and Country/Sub-region) o China § By Product Type o Japan § By Product Type o India § By Product Type o Australia § By Product Type o Southeast Asia § By Product Type o Rest of Asia Pacific § By Product Type · Latin America (By Product Type, Guidance System, Application, End-User, and Country/Sub-region) o Brazil § By Product Type o Mexico § By Product Type o Rest of Latin America § By Product Type · Middle East & Africa (By Product Type, Guidance System, Application, End-User, and Country/Sub-region) o GCC § By Product Type o South Africa § By Product Type o Rest of Middle East & Africa § By Product Type |
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )